Get Started

OCUL

NASD Ocular Therapeutix Inc
Oct 29, 2026 · 12:46 AM ET EOD Market Closed

$7.29 ↑ +0.00 (+0.00%) Trading Up from the previous close of $7.29, $0.05 below the day’s high of $7.34

YTD change
-39.95%
vs 20-day SMA
+3.58%
vs 200-day SMA
-20.51%

Price ranges

Previous day
$6.42 $6.75
open $6.48 close $6.72
+$0.24 (+3.70%)
Today
$6.60 $7.34
open $6.68 now $7.29
+$0.61 (+9.13%)
Past week
$6.35 $6.75
from $6.65 now $7.29
+$0.64 (+9.62%)
Past month
$6.00 $8.16
from $7.87 now $7.29
-$0.58 (-7.37%)
This year
$6.00 $13.03
from $12.14 now $7.29
-$4.85 (-39.95%)

Price & Performance

-2.03 (-21.78%) / 6M

$5.85$7.96$10.06$12.17Apr 28Jul 29Oct 28

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 70.0% away from all-time highs of $24.30
  • OCUL is down 40% since the beginning of the year
  • OCUL is down 37% over the past 12 months
  • OCUL is down 7% over the past 1 month
  • 14% of all OCUL investors are betting against OCUL

OCUL reads neutral: price sits above one of the two key moving averages, the 12-month move is -36.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.35
Earnings momentum +3.7% Quarterly EPS growth
Quarterly change +3.7%

Valuation

P/E ratio N/A
Enterprise value $992.4M
Beta 2.41

Balance sheet & scale

IncomeN/A
Revenue$52.1M
Cash$598.6M
Debt$79.4K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $1.6B

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,288.30 +0.50%
JNJ Johnson & Johnson $271.04 +0.86%
ABBV AbbVie, Inc. $285.99 -0.14%
MRK Merck & Co., Inc. $140.93 -0.63%
RHHVF Roche Holding Ltd $487.52 +1.44%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.